Author: Dr. David Lowemann

Zepbound Now in Single-Dose Vials at Half the Price

Eli Lilly, maker of one of the blockbuster GLP-1 weight-loss drug Zepbound, says it will now offer the medication in single-dose vials at half the price currently available to consumers. The new 2.5 milligram (mg) and 5 mg weekly dose vials differ from the standard preloaded… Read Full Article (External Site) Dr. David LowemannDr. David […]

Published on August 27, 2024

Brain research: Study shows what your favorite film genres reveal about your brain

Crime films, action films, comedies, or documentaries? A person’s favorite film genre reveals a lot about how their brain works. Fans of action films and comedies reacted very strongly to negative emotional stimuli, while participants who favored documentaries or crime films and thrillers had a significantly weaker reaction. Read Full Article (External Site) Dr. David […]

Published on August 27, 2024

New study supports annual breast cancer screening for women over 40

Women diagnosed with breast cancer who had regular screening mammograms every year were less likely to have late-stage cancer and had higher overall survival than those who received screening every other year or less often, according to new research. Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of […]

Published on August 27, 2024